A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

Researchers at Case Western Reserve University identified for the first time how HIV enters a dormant state in infected cells that allows the virus to “hide” from the immune system and current ...

A groundbreaking deal will make a new HIV prevention drug affordable in over 100 low-income countries, potentially advancing ...

For more than 20 years, the Duke Consortia for HIV/AIDS Vaccine Development had conducted its groundbreaking research with ...

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

Tick-borne encephalitis virus can infect the nervous system and cause life-threatening illness. Finding the cellular gateway ...

Lenacapavir, a Long-acting injectable drug used to prevent HIV, will be made available for $40 a year in over 120 low- and middle-income countries, under a new agreement announced this week between ...

It has been ten years since Brazil faced a major outbreak of the Zika virus. The alert was given in 2015, when the country's ...

Shares of Uniqure NV (NASDAQ:QURE) were trading at $43.52, up $29.86, or 218%, after the Amsterdam-based firm disclosed positive top-line data from the pivotal phase I/II study of AMT-130 for the ...